B-type natriuretic peptide shows a graded association with decline in kidney function in individuals with diabetes, even at concentrations ≤ 18.4 pg/mL, which are conventionally considered normal.

The report Cardiac Marker Testing Market size is estimated to be USD 3.6 billion in 2020 and projected to reach USD 5.5 billion by 2025, at a CAGR of 8.9. The growing incidence of cardiovascular ...

New York, Aug. 15, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cardiac Marker Testing Market Research Report by Type, by Product, by Disease, by Type of Testing - ...

Background Tricuspid annular plane systolic excursion (TAPSE) and right ventricular (RV) fractional area change (FAC) are ...

The "Global Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Disease (Myocardial Infarction, Congestive Heart Failure, ...

The Cardiac Marker Testing Market is estimated to be USD 3.6 billion in 2020 and projected to reach USD 5.5 billion by 2025, at a CAGR of 8.9%. According to the new market research report "Cardiac ...

A routine heart scan might soon do more than just check for clogged arteries; it could act as a crystal ball for your cardiac ...

HFpEF, a significant and common health burden that is increasing in prevalence, is associated with an elevated risk of SCD. In a retrospective analysis of data from the TOPCAT study, researchers ...

Consistent association seen for markers of systolic dysfunction with smaller total brain volume. (HealthDay News) — Subclinical cardiac dysfunction is associated with brain imaging markers of ...

DUBLIN, Feb. 1, 2021 /PRNewswire/ -- The "Global Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP ...

When examining data from 10,889 participants, researchers found a consistent association for markers of systolic dysfunction with smaller total brain volume. HealthDay News — Subclinical cardiac ...